LEXINGTON, Mass.--([ BUSINESS WIRE ])--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Patrick Vink, M.D., has joined the Company as Senior Vice President and General Manager of its International Business. In this new position reporting to Cubist President and COO Robert J. Perez, Dr. Vink will oversee Cubistas commercial opportunities across Europe and in select developing markets, as well as global partnerships.
"This is an incredible time to be joining Cubist"
Dr. Vink brings 25 years of global industry experience to Cubist, most recently serving as Senior Vice President, Global Head of Hospital Business and Global Head of Biologics for Mylan Inc. In this role, Dr. Vink coordinated all hospital business of the company. He joined Mylan in 2008, and established the companyas operations in Switzerland, which was the basis of a number of global functions. Dr. Vink was also responsible for the companyas biosimilars market entry.
Prior to Mylan, Dr. Vink held several leadership positions across the industry, including Head of Business Franchise Biopharmaceuticals for Novartis Sandoz; Director, Central Europe and VP International Sales for Biogen; and Head of Worldwide Marketing, Cardiovascular and Thrombosis for Sanofi-Synthelabo.
aPatrick brings extensive global experience to Cubist. His deep understanding of the international markets and strong track record of commercial success a" including the launch of several blockbuster products a" will be a tremendous asset to Cubist as we develop and implement our international strategy,a said Perez. aI also know Patrick to be a dynamic and insightful leader who shares Cubistas dedication to innovation and collaboration. I am confident that he will make a great additional to our leadership team.a
aThis is an incredible time to be joining Cubist,a said Dr. Vink. aThe company has great momentum and the wind at its back as it looks to grow its business and expand its global presence. Iam delighted to be joining the ranks of Cubistas talented team and look forward to working with the organization to build and develop its international business.a
Dr. Vink received his doctorate of medicine from the University of Leiden in the Netherlands and an MBA from Erasmus University/William E. Simon School. He lives with his wife and two children in Switzerland.
Dr. Vink will be based in Switzerland.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubistas web site at [ www.cubist.com ].
Photos/MultimediaGallery Available: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50395420&lang=en ]